Serpiginous Choroiditis

  • Reema Bansal
  • Amod Gupta
  • Aman Sharma
  • Kusum Sharma
  • Vishali Gupta


Serpiginous choroiditis (SC) is a chronic, recurrent inflammation, primarily affecting the choroid and choriocapillaris, with secondary involvement of the retinal pigment epithelium (RPE) and retina [1, 2]. It is usually bilateral, begins typically as peripapillary lesions of choroiditis, and spreads in a geographic pattern with remitting and relapsing clinical course [3]. The ultimate involvement of the fovea causes poor visual outcome. The etiology is not known, although an autoimmune mechanism has been speculated to be the underlying cause [4, 5]. Because of the morphologic pattern, it was previously known as geographic choroidopathy [6], or helicoid peripapillary chorioretinal degeneration [7], and subsequently termed serpiginoid choroiditis by Gass in 1970 [8].


Retinal Pigment Epithelium Tuberculin Skin Test Cystoid Macular Edema Active Lesion Final Visual Acuity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    AM A e-A. Serpiginous (geographical) choroiditis. Int Ophthalmol Clin. 1995;35:87–91.CrossRefGoogle Scholar
  2. 2.
    Lim WK, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol. 2005;50:231–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Weiss H, Annesley WH, Shields JA, et al. The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979;87:133–42.CrossRefPubMedGoogle Scholar
  4. 4.
    Laatikainen L, Erkkilä H. Serpiginous choroiditis. Br J Ophthalmol. 1974;58:777–83.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Erkkilä H, Laatikainen L, Jokinen E. Immunological studies on serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 1982;219:131–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Hamilton AM, Bird AC. Geographical choroidopathy. Br J Ophthalmol. 1974;58:784–97.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Babel J. Geographic and helicoid choroidopathies. Clinical and angiographic study; attempted classification. J Fr Ophtalmol. 1983;6:981–93.PubMedGoogle Scholar
  8. 8.
    Gass JDM. Stereoscopic atlas of macular diseases: a funduscopic and angiographic presentation. St Louis: CV Mosby, Co; 1970. p. 66.Google Scholar
  9. 9.
    Gupta V, Gupta A, Arora S, et al. Presumed tubercular serpiginouslike choroiditis: clinical presentations and management. Ophthalmology. 2003;110:1744–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P. Tubercular serpiginouslike choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology. 2012;119(11):2334–42.CrossRefPubMedGoogle Scholar
  11. 11.
    Khanamiri HN, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58:203–32.CrossRefGoogle Scholar
  12. 12.
    Vasconcelos-Santos DV, Rao PK, Davies JB, et al. Clinical features of tuberculous serpiginouslike choroiditis in contrast to classic serpiginous choroiditis. Arch Ophthalmol. 2010;128(7):853–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10:263–79.CrossRefPubMedGoogle Scholar
  14. 14.
    Carr RE, Noble KG. Disorders of the fundus. 8. Geographic (serpiginous) choroidopathy. Ophthalmology. 1980;87:1065–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Biswas J, Narain S, Das D, Ganesh SK. Pattern of uveitis in a referral uveitis clinic in India. Int Ophthalmol. 1996;20:223–8.PubMedGoogle Scholar
  16. 16.
    Fujisawa C, Fujiwara H, Hasegawa E, et al. The cases of serpiginous choroiditis (author’s transl). Nippon Ganka Gakkai Zasshi. 1978;82:135–43.PubMedGoogle Scholar
  17. 17.
    Gupta V, Agarwal A, Gupta A, et al. Clinical characteristics of serpiginous choroidopathy in North India. Am J Ophthalmol. 2002;134:47–56.CrossRefPubMedGoogle Scholar
  18. 18.
    Soheilian M, Heidari K, Yazdani S, et al. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12:297–310.CrossRefPubMedGoogle Scholar
  19. 19.
    Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11:277–86.CrossRefPubMedGoogle Scholar
  20. 20.
    Rathinam SR, Krishnadas R, Ramakrishnan R, et al. Population-based prevalence of uveitis in Southern India. Br J Ophthalmol. 2011;95:413–7.CrossRefGoogle Scholar
  21. 21.
    Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in North India. Indian J Ophthalmol. 2004;52:121–5.PubMedGoogle Scholar
  22. 22.
    Gan WL, Jones NP. Serpiginouslike choroiditis as a marker for tuberculosis in a non-endemic area. Br J Ophthalmol. 2013;97:644–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Abrez H, Biswas J, Sudarshan S. Clinical profile, treatment, and visual outcome of serpiginous choroiditis. Ocul Immunol Inflamm. 2007;15:325–35.CrossRefPubMedGoogle Scholar
  24. 24.
    Christmas NJ, Oh KT, Oh DM, et al. Long-term follow up of patients with serpiginous choroiditis. Retina. 2002;22:550–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Edelsten C, Stanford MR, Graham ER. Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis. Br J Ophthalmol. 1994;78:70–1.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Fiore PM, Friedman AH. Unusual chorioretinal degeneration associated with sarcoidosis. Am J Ophthalmol. 1988;106:490–1.CrossRefPubMedGoogle Scholar
  27. 27.
    Fuentes-Paez G, Celis-Sanchez J, Torres J, et al. Serpiginous choroiditis in a patient with systemic lupus erythematosus. Lupus. 2005;14:928–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Ugarte M, Wearne IM. Serpiginous choroidopathy: an unusual association with Crohn’s disease. Clin Experiment Ophthalmol. 2002;30:437–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Mulder CJ, Pena AS, Jansen J, et al. Celiac disease and geographic (serpiginous) choroidopathy with occurrence of thrombocytopenic purpura. Arch Intern Med. 1983;143:842.CrossRefPubMedGoogle Scholar
  30. 30.
    Pinto Ferreira F, Faria A, Ganhao F. Periarteritis nodosa with initial ocular involvement. J Fr Ophtalmol. 1995;18:788–93.PubMedGoogle Scholar
  31. 31.
    Rattray KM, Cole MD, Smith SR. Systemic non-Hodgkin’s lymphoma presenting as a serpiginous choroidopathy: report of a case and review of literature. Eye (Lond). 2000;14:706–10.CrossRefGoogle Scholar
  32. 32.
    Tang J, Fillmore G, Nussenblatt RB. Antiphospholipid antibody syndrome mimicking serpiginous choroidopathy. Ocul Immunol Inflamm. 2009;17:278–81.CrossRefPubMedGoogle Scholar
  33. 33.
    Erkkila H, Laatikainen L, Jokinen E. Immunological studies on serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 1982;219:131–4.CrossRefPubMedGoogle Scholar
  34. 34.
    King DG, Grizzard WS, Sever RJ, et al. Serpiginous choroidopathy associated with elevated factor VIII-von Willebrand factor antigen. Retina. 1990;10:97–101.CrossRefPubMedGoogle Scholar
  35. 35.
    Bansal R, Gupta A, Gupta V, et al. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008;146:772–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149:562–70.CrossRefPubMedGoogle Scholar
  37. 37.
    Mackensen F, Becker MD, Wiehler U, et al. QuantiFERON TB-gold—a New test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis. Am J Ophthalmol. 2008;146:761–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Gupta A, Bansal R, Gupta V, Sharma A. Fundus autofluorescence in serpiginous-like choroiditis. Retina. 2012;32:814–25.CrossRefPubMedGoogle Scholar
  39. 39.
    Rao NA, Saraswathy S, Smith RE. Tuberculous uveitis: distribution of mycobacterium tuberculosis in the retinal pigment epithelium. Arch Ophthalmol. 2006;124:1777–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Gass JDM. Stereoscopic atlas of macular diseases: a funduscopic and angiographic presentation. St Louis: CV Mosby, Co; 1997. p. 158–65.Google Scholar
  41. 41.
    Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment, vol. 1. 3rd ed. St Louis: Mosby; 1987. p. 136–44.Google Scholar
  42. 42.
    Priya K, Madhavan HN, Reiser BJ, et al. Association of herpes-viruses in the aqueous humor of patients with serpiginous choroiditis: a polymerase chain reaction-based study. Ocul Immunol Inflamm. 2002;10:253–61.CrossRefPubMedGoogle Scholar
  43. 43.
    Rodman J, Pizzimenti J. Serpiginous choroiditis in a herpes-positive patient. Optom Vis Sci. 2011;88:776–80.CrossRefPubMedGoogle Scholar
  44. 44.
    Mahendradas P, Kamath G, Mahalakshmi B, et al. Serpiginous choroiditis-like picture due to ocular toxoplasmosis. Ocul Immunol Inflamm. 2007;15:127–30.CrossRefPubMedGoogle Scholar
  45. 45.
    Thomas S, Wiselka M, Dhar J, Bibby K. Syphilis presenting as acute multifocal retinochoroiditis. J R Soc Med. 2006;99:371–2.PubMedCentralCrossRefPubMedGoogle Scholar
  46. 46.
    Tsimpida M, Low LC, Posner E, et al. Acute syphilitic posterior placoid chorioretinitis in late latent syphilis. Int J STD AIDS. 2009;20:207–8.CrossRefPubMedGoogle Scholar
  47. 47.
    Pisa D, Ramos M, Garcia P, et al. Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy. J Clin Microbiol. 2008;41:130–5.CrossRefGoogle Scholar
  48. 48.
    Portero A, Careno E, Real LA, Villaron S, Herreras JM. Infectious nontuberculous serpiginous choroiditis. Arch Ophthalmol. 2012;130:1207–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Bansal R, Kulkarni P, Gupta A, et al. High-resolution spectral domain optical coherence tomography and fundus autofluorescence correlation in tubercular serpiginouslike choroiditis. J Ophthal Inflamm Infect. 2011;1:157–63.CrossRefGoogle Scholar
  50. 50.
    Nayak S, Basu S, Singh MK. Presumed tubercular retinal vasculitis with serpiginous-like choroiditis in the other Eye. Ocul Immunol Inflamm. 2011;19:361–2.CrossRefPubMedGoogle Scholar
  51. 51.
    Znaor L, Medic A, Karaman K, Perkovic D. Serpiginous-like choroiditis as sign of intraocular tuberculosis. Med Sci Monit. 2011;17(7):CS88–90.PubMedCentralCrossRefPubMedGoogle Scholar
  52. 52.
    Masi RJ, O’Connor GR, Kimura SJ. Anterior uveitis in geographic or serpiginous choroiditis. Am J Ophthalmol. 1978;86:228–32.CrossRefPubMedGoogle Scholar
  53. 53.
    Bansal R, Gupta A, Gupta V. Imaging in the diagnosis and management of serpiginous choroiditis. Int Ophthal Clin. 2012;52:229–36.CrossRefPubMedGoogle Scholar
  54. 54.
    Schatz M, Maumenee AE, Patz A. Geographic helicoid peripapillary choroidopathy: clinical presentation and fluorescein angiographic findings. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:747–61.Google Scholar
  55. 55.
    Wolfensberger TJ, Piguet B, Herbort CP. Indocyanine green angiographic features in tuberculous chorioretinitis. Am J Ophthalmol. 1999;127:350–3.CrossRefPubMedGoogle Scholar
  56. 56.
    Giovannini A, Mariotti C, Ripa E, et al. Indocyanine green angiographic findings in serpiginous choroidopathy. Br J Ophthalmol. 1996;80:436–40.CrossRefGoogle Scholar
  57. 57.
    Giovannini A, Ripa E, Scassellati-Sforzolini B, et al. Indocyanine green angiography in serpiginous choroidopathy. Eur J Ophthalmol. 1996;6:299–306.PubMedGoogle Scholar
  58. 58.
    Cardillo Piccolino F, Grosso A, Savini E. Fundus autofluorescence in serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 2009;247:179–85.CrossRefPubMedGoogle Scholar
  59. 59.
    Punjabi OS, Rich R, Davis JL, et al. Imaging serpiginous choroidopathy with spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2008;39(4 Suppl):S95–8.PubMedGoogle Scholar
  60. 60.
    van Velthoven ME, Ongkosuwito JV, Verbraak FD, et al. Combined en-face optical coherence tomography and confocal ophthalmoscopy findings in active multifocal and serpiginous chorioretinitis. Am J Ophthalmol. 2006;141:972–5.CrossRefPubMedGoogle Scholar
  61. 61.
    Sharma K, Gupta V, Bansal R, Sharma A, Sharma M, Gupta A. Novel multitargeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inflamm Infect. 2013;3:25.PubMedCentralCrossRefPubMedGoogle Scholar
  62. 62.
    Wu JS, Lewis H, Fine SL, et al. Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina. 1989;9:292–301.CrossRefPubMedGoogle Scholar
  63. 63.
    Chisholm IH, Gass JD, Hutton WL. The late stage of serpiginous (geographic) choroiditis. Am J Ophthalmol. 1976;82:343–51.CrossRefPubMedGoogle Scholar
  64. 64.
    Jampol LM, Orth D, Daily MJ, et al. Subretinal neovascularization with geographic (serpiginous) choroiditis. Am J Ophthalmol. 1979;88:683–9.CrossRefPubMedGoogle Scholar
  65. 65.
    Laatikainen L, Erkkila H. Subretinal and disc neovascularization in serpiginous choroiditis. Br J Ophthalmol. 1982;66:326–31.PubMedCentralCrossRefPubMedGoogle Scholar
  66. 66.
    Lee DK, Suhler EB, Augustin W, et al. Serpiginous choroidopathy presenting as choroidal neovascularization. Br J Ophthalmol. 2003;87:1184–5.PubMedCentralCrossRefPubMedGoogle Scholar
  67. 67.
    Steinmetz RL, Fitzke FW, Bird AC. Treatment of cystoid macular edema with acetazolamide in a patient with serpiginous choroidopathy. Retina. 1991;11:412–5.CrossRefPubMedGoogle Scholar
  68. 68.
    Baglivo E, Boudjema S, Pieh C, et al. Vascular occlusion in serpiginous choroidopathy. Br J Ophthalmol. 2005;89:387–8.PubMedCentralCrossRefPubMedGoogle Scholar
  69. 69.
    Friberg TR. Serpiginous choroiditis with branch vein occlusion and bilateral periphlebitis. Case report. Arch Ophthalmol. 1988;106:585–6.CrossRefPubMedGoogle Scholar
  70. 70.
    Markomichelakis NN, Halkiadakis I, Papaethymiou-Orchan S, et al. Intravenous pulse methylprednisolone therapy for acute treatment of serpiginous choroiditis. Ocul Immunol Inflamm. 2006;14:29–33.CrossRefPubMedGoogle Scholar
  71. 71.
    Hoyng C, Tilanus M, Deutma A. Atypical central lesions in serpiginous choroiditis treated with oral prednisolone. Graefes Arch Clin Exp Ophthalmol. 1998;236:154–6.CrossRefPubMedGoogle Scholar
  72. 72.
    Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991;98:944–51. discussion 951-952.CrossRefPubMedGoogle Scholar
  73. 73.
    Nussenblatt RB. In discussion of Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology.1991;98:944–951, discussion 951–952Google Scholar
  74. 74.
    Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513.CrossRefPubMedGoogle Scholar
  75. 75.
    Akpek EK, Baltatzis S, Yang J, et al. Long-term immunosuppressive treatment of serpiginous choroiditis. Ocul Immunol Inflamm. 2001;9:147–67.CrossRefGoogle Scholar
  76. 76.
    Adiguzel U, Sari A, Ozmen C, et al. Intravitreal triamcinolone acetonide treatment for serpiginous choroiditis. Ocul Immunol Inflamm. 2006;14:375–8.CrossRefPubMedGoogle Scholar
  77. 77.
    Wadhwa N, Garg SP, Mehrotra A. Prospective evaluation of intravitreal triamcinolone acetonide in serpiginous choroiditis. Ophthalmologica. 2010;224:183–7.CrossRefPubMedGoogle Scholar
  78. 78.
    Gupta V, Bansal R, Gupta A. Continuous Progression of Tubercular Serpiginous-like Choroiditis After Initiating Antituberculosis Treatment. Am J Ophthalmol. 2011;152:857–63.CrossRefPubMedGoogle Scholar
  79. 79.
    Basu S, Das T. Pitfalls in the management of TB-associated uveitis. Eye. 2010;24(11):1681–4.CrossRefPubMedGoogle Scholar
  80. 80.
    Gupta V, Gupta A, Rao NA. Intraocular tuberculosis- an update. Surv Ophthalmol. 2007;52(6):561–87.CrossRefPubMedGoogle Scholar
  81. 81.
    Cheung CM, Chee SP. Jarisch–Herxheimer reaction: paradoxical worsening of tuberculosis chorioretinitis following initiation of antituberculous therapy. Eye. 2009;23(6):1472–3.CrossRefPubMedGoogle Scholar
  82. 82.
    Arevalo JF, Adan A, Berrocal MH, et al. Intravitreal Bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Retina. 2011;31:347–63.CrossRefGoogle Scholar
  83. 83.
    Rouvas A, Petrou P, Douvali M, et al. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina. 2011;31:871–9.CrossRefPubMedGoogle Scholar
  84. 84.
    Mansour AM, Arevalo JF, Ziemssen F, et al. Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol. 2009;148:310.e2–6.e2.CrossRefGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  • Reema Bansal
    • 1
  • Amod Gupta
    • 1
  • Aman Sharma
    • 2
  • Kusum Sharma
    • 3
  • Vishali Gupta
    • 1
  1. 1.Advanced Eye CentrePost Graduate Institute of Medical Education and ResearchChandigarhIndia
  2. 2.Department of Internal MedicinePost Graduate Institute of Medical Education and ResearchChandigarhIndia
  3. 3.Department of MicrobiologyPost Graduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations